Boyd Rutten joined the Gilde Healthcare PE team in 2019. He is involved in deal origination, assessment of investment cases, (dis)investment processes and portfolio management. Boyd is actively involved with portfolio company Eetgemak.

Prior to joining Gilde Healthcare, Boyd gained Private Equity experience at EQT Partners focusing on European Mid-Market transactions. Before that he spent six years in Investment Banking at ING Corporate Finance.

Boyd holds a M.Sc. in Finance & Investments from Erasmus University in Rotterdam and spent part of his curriculum at Brandeis University – International Business School, Waltham, USA.